|
End-of-day quote
Taiwan S.E.
28/08/2026
|
5-day change | 1st Jan Change | ||
| 1,545.00 TWD | -0.96% |
|
+10.36% | +264.65% |
| 29/08 | US FDA approves Takeda, Protagonist's drug for rare blood cancer | RE |
| 17/08 | PharmaEssentia Corp Submits Post-approval Applications to Taiwan Regulator to Expand Besremi Use | MT |
| Market Cap | 640B 20.25B 17.46B 16.36B 14.94B 28.11B 1,931B 28.29B 194B 75.72B 976B 76.01B 74.36B 3,242B | P/E 2026 * |
58.3x | P/E 2027 * | 37.9x |
|---|---|---|---|---|---|
| Enterprise Value | 614B 19.41B 16.73B 15.69B 14.32B 26.95B 1,851B 27.12B 186B 72.58B 936B 72.86B 71.28B 3,107B | EV / Sales 2026 * |
21.7x | EV / Sales 2027 * | 15.6x |
| Free-Float |
77.98% | Yield 2026 * |
0.26% | Yield 2027 * | 0.15% |
| 1 day | -0.96% | ||
| 1 week | +10.36% | ||
| Current month | +45.75% | ||
| 1 month | +43.06% | ||
| 3 months | +84.28% | ||
| 6 months | +136.72% | ||
| Current year | +264.65% |
| 1 week | 1,405 |  | 1,640 |
| 1 month | 1,045 | | 1,640 |
| Current year | 423.7 | | 1,640 |
| 1 year | 400.89 | | 1,640 |
| 3 years | 228.27 | | 1,640 |
| 5 years | 56.05 | | 1,640 |
| 10 years | 43.54 | | 1,640 |
| Manager | Title | Age | Since |
|---|---|---|---|
Kuo Chung Lin
CEO | Chief Executive Officer | - | 01/01/2017 |
Hsueh Ling Chang
DFI | Director of Finance/CFO | - | 14/10/2015 |
Cheng Ku Huang
PSD | President | - | 25/06/2015 |
| Director | Title | Age | Since |
|---|---|---|---|
Kuo Chung Lin
BRD | Director/Board Member | - | 09/05/2000 |
Ching-Leou Teng
CHM | Chairman | - | 24/09/2012 |
Cheng Ku Huang
BRD | Director/Board Member | - | 29/05/2015 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.96% | +10.36% | +283.06% | +436.50% | 20.22B | |
| -1.59% | -3.35% | +52.37% | +93.70% | 69.54B | |
| -1.34% | -0.75% | +48.21% | +91.86% | 64.97B | |
| +0.30% | -0.69% | +52.56% | +10.23% | 26.51B | |
| -2.35% | -5.75% | -12.90% | +448.54% | 25.89B | |
| -8.37% | -12.43% | +2.08% | -16.71% | 25.64B | |
| -0.51% | +0.23% | +35.77% | -18.70% | 19.98B | |
| -1.91% | -4.37% | +13.28% | +535.19% | 15.69B | |
| -1.47% | +0.68% | +45.51% | +143.08% | 13.49B | |
| -1.83% | +3.29% | +21.90% | +197.38% | 12.33B | |
| Average | -2.00% | -1.40% | +54.18% | +192.11% | 29.43B | |
| Weighted average by Cap. | -1.93% | -1.30% | +52.39% | +153.43% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 28.33B 896M 772M 724M 661M 1.24B 85.42B 1.25B 8.6B 3.35B 43.2B 3.36B 3.29B 143B | 38.77B 1.23B 1.06B 991M 905M 1.7B 117B 1.71B 11.76B 4.58B 59.12B 4.6B 4.5B 196B |
| Net income | 11.02B 349M 300M 282M 257M 484M 33.24B 487M 3.34B 1.3B 16.81B 1.31B 1.28B 55.8B | 17.1B 541M 466M 437M 399M 751M 51.55B 755M 5.19B 2.02B 26.07B 2.03B 1.99B 86.55B |
| Net Debt | -26.52B -839M -723M -678M -619M -1.16B -79.98B -1.17B -8.05B -3.14B -40.45B -3.15B -3.08B -134B | -34.73B -1.1B -947M -888M -810M -1.52B -105B -1.53B -10.54B -4.11B -52.96B -4.12B -4.03B -176B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 28/08/26 | TWD 1,545.00 | -0.96% | 4,112,305 |
| 27/08/26 | TWD 1,560.00 | -1.58% | 3,952,150 |
| 26/08/26 | TWD 1,585.00 | +6.38% | 3,972,402 |
| 25/08/26 | TWD 1,490.00 | +1.02% | 5,309,944 |
| 24/08/26 | TWD 1,475.00 | +5.36% | 3,304,095 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 6446 Stock
Select your edition
All financial news and data tailored to specific country editions
